title: Response to Dr Minota's Letter to the Editor of Modern Rheumatology Regarding a Study of Tofacitinib in Japanese Patients with Rheumatoid Arthritis.
authors: a The First Department of Internal Medicine , School of Medicine, University of Occupational and Environmental Health , Japan, Kitakyushu , Japan.
authors: Yoshiya
authors: Y
authors: Tanaka
authors: b Pfizer Inc , New London , CT , USA.
authors: Samuel H
authors: SH
authors: Zwillich
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D056747:Immunomodulation; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage*; D011758:Pyrroles / Q000008:administration & dosage*
chemical_list: D018501:Antirheumatic Agents; D011743:Pyrimidines; D011758:Pyrroles; D008727:Methotrexate